Vitamin D/ja: Difference between revisions
Vitamin D/ja
Created page with "ビタミン D" Tags: Mobile edit Mobile web edit |
Created page with "{{Infobox drug class |Synonyms= Calciferols | Image = Cholecalciferol2.svg | Alt = | Caption = コレカルシフェロール (D<sub>3</sub>) | Use = Rickets/ja, osteoporosis/ja, ビタミン D 欠乏症 | MeshID = D014807 | Consumer_Reports = | ATC_prefix = A11CC | medicinenet = | rxlist = | Drugs.com = {{Drugs.com|npp|vitamin-d}} | Biological_target = ビタミン D 受容体 }} '''ビタミンD'''はLipophilicity/j..." Tags: Mobile edit Mobile web edit |
||
Line 1: | Line 1: | ||
<languages /> | <languages /> | ||
{{Infobox drug class | {{Infobox drug class | ||
|Synonyms= Calciferols | |Synonyms= Calciferols | ||
| Image = Cholecalciferol2.svg | | Image = Cholecalciferol2.svg | ||
| Alt = | | Alt = | ||
| Caption = [[Cholecalciferol]] (D<sub>3</sub>) | | Caption = [[Cholecalciferol/ja]] (D<sub>3</sub>) | ||
| Use = [[Rickets]], [[osteoporosis]], [[hypovitaminosis D| | | Use = [[Rickets/ja]], [[osteoporosis/ja]], [[hypovitaminosis D/ja|ビタミン D 欠乏症]] | ||
| MeshID = D014807 | | MeshID = D014807 | ||
| Consumer_Reports = | | Consumer_Reports = | ||
Line 14: | Line 12: | ||
| rxlist = | | rxlist = | ||
| Drugs.com = {{Drugs.com|npp|vitamin-d}} | | Drugs.com = {{Drugs.com|npp|vitamin-d}} | ||
| Biological_target = [[calcitriol receptor| | | Biological_target = [[calcitriol receptor/ja|ビタミン D 受容体]] | ||
}} | }} | ||
''' | '''ビタミンD'''は[[Lipophilicity/ja|脂溶性]] [[secosteroid/ja|セコステロイド]]の一群である。[[calcium/ja|カルシウム]]、[[magnesium/ja|マグネシウム]]、[[phosphate/ja|リン酸塩]]の腸管吸収を増加させ、他の多くの生物学的作用を担う。ヒトにおいて、このグループの最も重要な化合物はビタミンD<sub>3</sub>([[cholecalciferol/ja|コレカルシフェロール]])とビタミンD<sub>2</sub>([[ergocalciferol/ja|エルゴカルシフェロール]])である。 | ||
<div lang="en" dir="ltr" class="mw-content-ltr"> | <div lang="en" dir="ltr" class="mw-content-ltr"> |